Is Enlivex Therapeutics Ltd. (ENLV) a Buy, Sell, or Hold?
NASDAQ : ENLV
Enlivex Therapeutics Ltd. — Insider Trades
$2.09 USD
$0.14 (7.18%)
- Volume
- 338.61K
- Average Volume
- 114.57K
- Market Capitalization
- $35.18M
- P/E Ratio
- 0.01
- Dividend Yield
- 0.00%
- Price Target
- $15.00
- Year High
- $31.50
- Year Low
- $1.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $193.24
Insider Activity Summary (Last 12 Months)
Insiders Buying
0
Insiders Selling
0
Amount of Insider Selling
-$
ENLV Insider Buying/Selling by Quarter
ENLV Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Hershkovitz Oren | officer: Chief Executive Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Hershkovitz Oren | officer: Chief Executive Officer | 2023-11-16 | 8.19 | 2026-03-18 | |
| Hershkovitz Oren | officer: Chief Executive Officer | 2025-11-24 | 5.34 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2021-03-07 | 2.69 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2021-12-12 | 6.22 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2024-03-30 | 4.68 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2022-12-10 | 10.12 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2025-11-24 | 3.21 | 2026-03-18 | |
| Shlosberger Shachar | officer: Chief Financial Officer | 2025-11-24 | 5.34 | 2026-03-18 | |
| Hart Gili | director | 2026-03-18 | 0 | 2026-03-18 | |
| Hart Gili | director | 2019-06-01 | 2.69 | 2026-03-18 | |
| Hart Gili | director | 2026-03-18 | 5.34 | 2026-03-18 | |
| NOVIK SHAI A | director | 2026-03-18 | 0 | 2026-03-18 | |
| NOVIK SHAI A | director | 2021-12-12 | 6.22 | 2026-03-18 | |
| NOVIK SHAI A | director | 2023-05-03 | 3.66 | 2026-03-18 | |
| NOVIK SHAI A | director | 2024-05-28 | 12.23 | 2026-03-18 | |
| NOVIK SHAI A | director | 2025-11-17 | 5.34 | 2026-03-18 | |
| NOVIK SHAI A | director | 2019-06-01 | 2.69 | 2026-03-18 | |
| Pomerantz Roger | director | 2026-03-18 | 0 | 2026-03-18 | |
| Pomerantz Roger | director | 2026-03-18 | 5.967 | 2026-03-18 | |
| Havron Avraham | director | 2026-03-18 | 0 | 2026-03-18 | |
| Havron Avraham | director | 2019-06-01 | 2.69 | 2026-03-18 | |
| Havron Avraham | director | 2026-03-18 | 5.34 | 2026-03-18 | |
| Galamidi Einat | officer: Chief Medical Officer | 2026-03-18 | 0 | 2026-03-18 | |
| Galamidi Einat | officer: Chief Medical Officer | 2025-11-24 | 5.34 | 2026-03-18 | |
| Galamidi Einat | officer: Chief Medical Officer | 2025-11-24 | 3.21 | 2026-03-18 | |
| Murray Michael Anthony | other: former SVP - Operations | 2015-10-09 | S-Sale | 2.78 | 2015-10-27 |
| WEATHERSON HARVEY D | director | 2008-01-02 | A-Award | 1.25 | 2008-01-04 |
| RANEY DENNIS R | director | 2008-01-02 | A-Award | 1.25 | 2008-01-04 |